6Garolyn AF, Beverly JL, Judith MC, Pediatric Acute Lymphoblastie Leukemia: Challenges and Controaversies in 2000, in Hematology 2000 American Society of Hematoloagy Education Program Book. San Francisco, California, pp 285-302.
7Rosario LA, O' Brien ML, Henderson CJ, et al. Cellular response to a glutathione S-transferase PI-1 activated prodrug. Mol Pharmacol, 2000, 58:167-174.
8Gu LJ, Ye QD, Liang AB, et al. Thiopurine methyltransferase(TPMT) activity and its relation to thioguanine nucleotide level in Chinese children with acute lymphoblastic leukemia. Blood,2001, 98:310a.
9Dübbers A, Würthwein G, Müller HJ, et al. Asparagine synthetase activity in paediatric acute leukaemias: AML-M5 subtype shows lowest activity, Br J Haematol, 2000, 109:427-429,.
5L. Lennard. The clinical pharmacology of 6-mercaptopurine[J] 1992,European Journal of Clinical Pharmacology(4):329～339
6Wang A,Boos J.Unphysiological effects contributing to asparaginase toxicity in vitro[].American Journal of Physiology.1998
7Dubbers A,Wurthwein G,Muller HJ,et al.Asparaginase syn-thetase activity in paediatric acute leukemias: AML-M5 subtype shows lowest activity[].British Journal of Haematology.2000
8Bussolati O,Belletti S,Uggeri J,et al.Characterization of appo-totic phenomena induced by treated with L-asparaginase in Nih-3T3 cells[].Experimental Cell Research.1995
9Vieria Pinheiro JP,Ahlke E,Nowak-Gottl U,et al.Pharma-cokinetic dose adjustment of Erwinia asparaginase in protocol II of the paediatric ALL/NHL-BFM treatment protocols[].British Journal of Haematology.1999
10Pieters R,Den Boer ML,Durian M,et al.Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia-implications for treatment of infants[].Leukemia.1998
6Pui CH, Evans WE. Treatment of acute lymphoblastic leukemia. N Engl J Med,2006,354(2):166-178.
7Pui CH, Relling MV, Sandlund JT, et al. Retionale and design of Total Therapy Study X V for newly diagnosed childhood acute lymphoblastic leukemia. Ann Hematol, 2004,83 (Suppl 1) : S124- S126.
8Sallan SE. Myths and Lessons from the Adult/Pediatric Interface in Acute Lymphoblastic Leukemia. Hematology 2006, American Society of Hematology Education Program Book,p128-132.
9DeAngelo DJ, The Treatment of Adolescents and Young Adults with Acute Lymphoblastic Leukemia. Hematology 2005, American Society of Hematology Education Program Book, p123-130.
10Chessells JM, Hall E, Prentice HG, et al. , The impact of age on outcome in lymphoblastic leukemia;MRC UKALL X and XA compared: a report from the MRC Paediatrie and Adult Working Parties. Leukemia, 1998;12(4) :463-473.
